US Patent 7655426 Ephrin-B receptor protein involved in carcinoma
All edits
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+264 characters)
Article
Patent abstract
The present invention provides a polypeptide (CCMP-1) of use in the diagnosis, screening, treatment and prophylaxis of carcinoma. Also provided are compositions comprising the protein, vaccines and antibodies that are immunospecific for the protein.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07655426 Ephrin-B receptor protein involved in carcinoma US Patent 7655426 Ephrin-B receptor protein involved in carcinoma
Infobox
Patent Number
0765542600
Patent Number
765542600
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
076554260
Date of Patent
February 2, 2010
0Patent Application Number
105105240
Date Filed
April 9, 2003
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
076554260
Date of Patent
February 2, 2010
0Patent Application Number
105105240
Date Filed
April 9, 2003
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07655426 Ephrin-B receptor protein involved in carcinoma
Infobox
Is a
Patent jurisdiction
Patent number
07655426
Date of patent
February 2, 2010
Patent application number
10510524
Date Filed
April 9, 2003
Patent primary examiner
Find more entities like US Patent 7655426 Ephrin-B receptor protein involved in carcinoma
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
